Naju-si, South Korea

Eun Ah Kim



Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Eun Ah Kim: Pioneering Anti-Inflammatory Solutions from Naju-si, South Korea

Introduction: Eun Ah Kim is an accomplished inventor based in Naju-si, South Korea, known for her significant contributions to the field of bioscience. With her noteworthy patent, she has made strides in developing therapeutic compositions aimed at addressing inflammatory, allergic, and asthmatic diseases.

Latest Patents: Eun Ah Kim holds one patent, which focuses on a unique composition comprising an extract of tiarellic acid. This invention demonstrates remarkable anti-inflammatory, anti-allergic, and anti-asthmatic activity. The data show that the extract and isolated tiarellic acid effectively inhibit LTCrelease in vitro and reduce IgE levels, as well as cytokine production (IL-4, IL-5, and IL-13). Additionally, it has shown promising results in alleviating airway hyperresponsiveness and leukocyte infiltration in OVA-induced asthmatic mice. This invention highlights the potential for use as therapeutics or functional health food for treating and preventing various diseases.

Career Highlights: Eun Ah Kim is associated with the Korea Research Institute of Bioscience and Biotechnology, where she engages in cutting-edge research and development. Her passion for scientific inquiry and innovation has positioned her as a notable figure within her field.

Collaborations: Throughout her career, Eun Ah Kim has collaborated with esteemed colleagues such as Hyeong Kyu Lee and Sei Ryang Oh, contributing to the advancement of bioscience research and innovation.

Conclusion: With a clear dedication to advancing healthcare solutions, Eun Ah Kim's innovations offer significant promise in the treatment of asthma and related conditions. Her contributions at the Korea Research Institute of Bioscience and Biotechnology reflect the impact of interdisciplinary collaboration in driving forward-effective therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…